ABBV

ABBV

USD

AbbVie Inc. Common Stock

$215.890+3.520 (1.657%)

السعر في الوقت الحقيقي

Healthcare
Drug Manufacturers - General
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$212.370

الأعلى

$217.080

الأدنى

$212.370

الحجم

6.49M

أساسيات الشركة

القيمة السوقية

381.4B

الصناعة

Drug Manufacturers - General

البلد

United States

إحصاءات التداول

متوسط الحجم

5.41M

البورصة

NYQ

العملة

USD

نطاق 52 أسبوعاً

الأدنى $163.81الحالي $215.890الأعلى $244.81

أخبار ذات صلة

Analyst Upgrades

Citigroup Maintains Neutral on AbbVie, Lowers Price Target to $235

Citigroup analyst Geoff Meacham maintains AbbVie with a Neutral and lowers the price target from $240 to $235.

عرض المزيد
Citigroup Maintains Neutral on AbbVie, Lowers Price Target to $235
Analyst Upgrades

JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $260

JP Morgan analyst Chris Schott maintains AbbVie with a Overweight and raises the price target from $250 to $260.

عرض المزيد
JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $260
Analyst Upgrades

AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

AbbVie beats Q3 estimates with $15.78 billion revenue, boosts dividend to $1.73, raises earnings outlook on strong drug portfolio growth.

عرض المزيد
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
PR Newswire

AbbVie Reports Third-Quarter 2025 Financial Results

AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2025. "AbbVie continues to deliver outstanding results, with ...

عرض المزيد
AbbVie Reports Third-Quarter 2025 Financial Results
PR Newswire

The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the seventh annual BOTOX® Cosmetic Day will take place on Wednesday, November...

عرض المزيد
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year
PR Newswire

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

AbbVie (NYSE: ABBV) today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib...

CNBC

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.